SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-007293
Filing Date
2024-01-26
Accepted
2024-01-26 16:33:02
Documents
1
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244260-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm244260-3_4seq1.xml 4 4256
  Complete submission text file 0001104659-24-007293.txt   6041
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address OPKO HEALTH, INC. 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address
Rubin Steven D (Reporting) CIK: 0001381874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 24568387